FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Monika Jung

Research Profile

Disorders

Procedures

Physiology

Gene Expression Regulation, Neoplastic

Chemicals & Drugs

Anatomy

Prostate

Concepts & Ideas

RNA Stability

Co-author Network

Publications

TOP 3
Zofia Wotschofsky; Jonas Busch; Andreas Erbersdobler; Monika Jung; Carsten Kempkensteffen; Ergin Kilic; Glen Kristiansen; Ingo Melcher; Kurt Miller; Klaus D Schaser; Steffen Weikert; Klaus Jung
Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy.
Zofia Wotschofsky; Jonas Busch; Alexander C Disch; Andreas Erbersdobler; Monika Jung; Ergin Kilic; Julia Liep; Ingo Melcher; Hellmuth-Alexander Meyer; Kurt Miller; Hans-Joachim Mollenkopf; Klaus-Dieter Schaser; Ina Wagner; Steffen Weikert; Klaus Jung
Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.
Nadine Ratert; Ina Wagner; Steffen Weikert; Andreas Erbersdobler; Monika Jung; Ergin Kilic; Hellmuth-Alexander Meyer; Kurt Miller; Hans-Joachim Mollenkopf; Klaus Jung
Reference miRNAs for miRNAome analysis of urothelial carcinomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Monika Jung (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Zofia Wotschofsky; Jonas Busch; Andreas Erbersdobler; Monika Jung; Carsten Kempkensteffen; Ergin Kilic; Glen Kristiansen; Ingo Melcher; Kurt Miller; Klaus D Schaser; Steffen Weikert; Klaus Jung
Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy.
Clinica chimica acta; international journal of clinical chemistry 2013;416():5-10.
2012: Zofia Wotschofsky; Jonas Busch; Alexander C Disch; Andreas Erbersdobler; Monika Jung; Ergin Kilic; Julia Liep; Ingo Melcher; Hellmuth-Alexander Meyer; Kurt Miller; Hans-Joachim Mollenkopf; Klaus-Dieter Schaser; Ina Wagner; Steffen Weikert; Klaus Jung
Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.
International journal of biological sciences 2012;8(10):1363-74.
2012: Nadine Ratert; Ina Wagner; Steffen Weikert; Andreas Erbersdobler; Monika Jung; Ergin Kilic; Hellmuth-Alexander Meyer; Kurt Miller; Hans-Joachim Mollenkopf; Klaus Jung
Reference miRNAs for miRNAome analysis of urothelial carcinomas.
PloS one 2012;7(6):e39309.
2011: Angelika Tölle; Saba Suhail; Klaus Jung; Monika Jung; Carsten Stephan
Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma.
BMC cancer 2011;11():302.
2010: Annika Schaefer; Monika Jung; Kurt Miller; Michael Lein; Glen Kristiansen; Andreas Erbersdobler; Klaus Jung
Suitable reference genes for relative quantification of miRNA expression in prostate cancer.
Experimental & molecular medicine 2010;42(11):749-58.
2010: Anja Rabien; Florian R Fritzsche; Monika Jung; Angelika Tölle; Eleftherios P Diamandis; Kurt Miller; Klaus Jung; Glen Kristiansen; Carsten Stephan
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
International journal of cancer. Journal international du cancer 2010;127(10):2386-94.
2010: Monika Jung; Annika Schaefer; Isabel Steiner; Carsten Kempkensteffen; Carsten Stephan; Andreas Erbersdobler; Klaus Jung
Robust microRNA stability in degraded RNA preparations from human tissue and cell samples.
Clinical chemistry 2010;56(6):998-1006.
2010: Annika Schaefer; Monika Jung; Glen Kristiansen; Michael Lein; Mark Schrader; Kurt Miller; Carsten Stephan; Klaus Jung
MicroRNAs and cancer: current state and future perspectives in urologic oncology.
Urologic oncology 2010;28(1):4-13.
2009: Monika Jung; Hans-Joachim Mollenkopf; Christina Grimm; Ina Wagner; Marco Albrecht; Tobias Waller; Christian Pilarsky; Manfred Johannsen; Carsten Stephan; Hans Lehrach; Wilfried Nietfeld; Thomas Rudel; Klaus Jung; Glen Kristiansen
MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.
Journal of cellular and molecular medicine 2009;13(9B):3918-28.
2008: Florian R Fritzsche; Monika Jung; Angelika Tölle; Peter Wild; Arndt Hartmann; Kirsten Wassermann; Anja Rabien; Michael Lein; Manfred Dietel; Christian Pilarsky; Daniela Calvano; Robert Grützmann; Klaus Jung; Glen Kristiansen
ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer.
European urology 2008;54(5):1097-106.
2008: Anja Rabien; Florian R Fritzsche; Monika Jung; Eleftherios P Diamandis; Stefan A Loening; Manfred Dietel; Klaus Jung; Carsten Stephan; Glen Kristiansen
High expression of KLK14 in prostatic adenocarcinoma is associated with elevated risk of prostate-specific antigen relapse.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(1):1-8.
2007: Anja Rabien; Monika Jung; Florian R Fritzsche; Stefan A Loening; Glen Kristiansen; Klaus Jung
[Tumor suppressor RECK in prostate carcinoma. Decreased RECK expression as indicator of proteolytic imbalance].
Der Urologe. Ausg. A 2007;46(9):1081-2.
2007: Monika Jung; Falk Ohl; Carsten Stephan; Anja Rabien; Glen Kristiansen; A Radonić; Stefan A Loening; Klaus Jung
[Quantifying gene expression in prostate carcinoma. Which endogenous reference genes are suitable?].
Der Urologe. Ausg. A 2007;46(9):1083-4.
2007: Anja Rabien; Mick Burkhardt; Monika Jung; Florian R Fritzsche; Martin Ringsdorf; Hanka Schicktanz; Stefan A Loening; Glen Kristiansen; Klaus Jung
Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
European urology 2007;51(5):1259-66.
2007: Monika Jung; Azizbek Ramankulov; Jan Roigas; Manfred Johannsen; Martin Ringsdorf; Glen Kristiansen; Klaus Jung
In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR.
BMC molecular biology 2007;8():47.
2006: Florian R Fritzsche; Monika Jung; Chuanliang Xu; Anja Rabien; Hanka Schicktanz; Carsten Stephan; Manfred Dietel; Klaus Jung; Glen Kristiansen
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.
Virchows Archiv : an international journal of pathology 2006;449(6):628-36.
2006: Falk Ohl; Monika Jung; Aleksandar Radonić; Markus Sachs; Stefan A Loening; Klaus Jung
Identification and validation of suitable endogenous reference genes for gene expression studies of human bladder cancer.
The Journal of urology 2006;175(5):1915-20.
2005: Falk Ohl; Monika Jung; Chuanliang Xu; Carsten Stephan; Anja Rabien; Mick Burkhardt; Andreas Nitsche; Glen Kristiansen; Stefan A Loening; Aleksandar Radonić; Klaus Jung
Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?
Journal of molecular medicine (Berlin, Germany) 2005;83(12):1014-24.
2005: Martina Geheeb; Anja Rabien; Falk Ohl; Monika Jung; Klaus Jung
Misinterpretation of quantitative RT-PCR results: A comment on the article by Ohashi et al. "RNA degradation in human breast tissue after surgical removal: a time course study", Exp. Mol. Pathol. 77 (2004) 98-103.
Experimental and molecular pathology 2005;78(3):263; author reply 264.
2005: Chuanliang Xu; Monika Jung; Mick Burkhardt; Carsten Stephan; Dietmar Schnorr; Stefan A Loening; Klaus Jung; Manfred Dietel; Glen Kristiansen
Increased CD59 protein expression predicts a PSA relapse in patients after radical prostatectomy.
The Prostate 2005;62(3):224-32.